Grants and Contributions:
Title:
Introducing CAVU products to the Shanghai market
Agreement Number:
923150
Agreement Value:
$49,965.00
Agreement Date:
Feb 20, 2019 - Nov 30, 2019
Description:
We export drugs through Canadian pharmaceutical firms, PHARMASCIENCE, BIOLYSE PHARMA, LERNA PHARMA and lOMÉGA Ltée, to the Ivory Coast and Senegal, and diversify our operations in Cameroon.
Organization:
National Research Council Canada
Expected Results:
CanExport is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Location:
Victoria, British Columbia, CA V8W 1W2
Reference Number:
172-2018-2019-Q4-923150
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
819425182
Recipient Type:
For-profit organization
Recipient's Legal Name:
CAVU Designwerks, INC.
Federal Riding Name:
Victoria
Federal Riding Number:
59041
Program:
CanExport
Program Purpose:
CanExport is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Coverage:
CanExport projects lead to increased export diversification and growth for Canadian small and medium enterprises.
NAICS Code:
541330